Ligand Pharmaceuticals (LGND) Interest Coverage Ratio (2010 - 2026)

Ligand Pharmaceuticals has disclosed Interest Coverage Ratio across 17 years of filings, most recently posting 9.94 for Q1 2026.

• Interest Coverage Ratio for Q1 2026 came in at 9.94, up 123.8% year-over-year; the trailing twelve-month figure through Mar 2026 was 16.91 (up 202.81% YoY), and the FY2025 annual result was 8.7, up 216.83% from the prior year.
• Interest Coverage Ratio came in at 9.94 for Q1 2026 at Ligand Pharmaceuticals, up from 7.76 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 3078.0 in Q3 2023 to a low of 83.75 in Q4 2022.
• The 5-year median for Interest Coverage Ratio is 7.32 (2025), against an average of 183.74.
• Across the five-year window, Interest Coverage Ratio plunged 1092.11% in 2022 and soared 8180.5% in 2023, its largest moves.
• Ligand Pharmaceuticals' Interest Coverage Ratio stood at 83.75 in 2022, then surged by 69.39% to 25.63 in 2023, then surged by 57.42% to 10.91 in 2024, then soared by 171.06% to 7.76 in 2025, then increased by 28.19% to 9.94 in 2026.
• The last three Interest Coverage Ratio figures came in at 9.94 (Q1 2026), 7.76 (Q4 2025), and 60.36 (Q3 2025), per Business Quant data.